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Escherichia coli is the primary cause of urinary tract infection (UTI) in the developed world. The major
factors associated with the virulence of uropathogenic E. coli (UPEC) are fimbrial adhesins, which mediate
specific attachment to host receptors and trigger innate host responses. Another group of adhesins is repre-
sented by the autotransporter subgroup of proteins. The best characterized of these proteins, antigen 43
(Ag43), is a self-recognizing adhesin that is associated with cell aggregation and biofilm formation in E. coli
K-12. The sequenced genome of prototype UPEC strain CFT073 contains two variant Ag43-encoding genes
located on pathogenicity islands. The biological significance of both of these genes and their role in UPEC
pathogenesis have not been investigated previously. Here we performed a detailed molecular characterization
analysis of Ag43a (c3655) and Ag43b (c1273) from UPEC CFT073. Expression of Ag43a and Ag43b in a K-12
background revealed that they possess different functional properties. Ag43a produced a strong aggregation
phenotype and promoted significant biofilm growth. Deletion mutants and strains constitutively expressing
Ag43a and Ag43b were also constructed using CFT073. When these mutants were analyzed in a mouse model
of UTI, Ag43a (but not Ag43b) promoted long-term persistence in the urinary bladder. Our findings demon-
strate that Ag43a contributes to UPEC disease pathogenesis and reveal that there are pathogenicity-adapted
variants of Ag43 with distinct virulence-related functions.
Urinary tract infections (UTI), which start as bladder infec-
tions and often evolve to encompass the kidneys, are among
the most common infectious diseases of humans. It is esti-
mated that 40 to 50% of adult healthy women have experi-
enced at least one UTI episode in their lifetime, and there is a
tendency for these infections to become chronic due to a high
rate of recurrence. Escherichia coli is the cause of the majority
(80%) of UTI in humans and is one of the most common
sources of gram-negative bacteremia in hospitalized patients.
Almost all patients with an indwelling urinary catheter that is
present for 30 days or longer develop catheter-associated UTI,
which account for 40% of all nosocomial infections (11).
The ability of uropathogenic E. coli (UPEC) to colonize the
urinary tract involves adhesins (e.g., type 1 and P fimbriae) and
toxins (e.g., hemolysin) (27, 33). Adherence to the urinary tract
epithelium enables the bacteria to resist the hydrodynamic
forces of urine flow, to trigger host and bacterial cell signaling
pathways, and to establish an infection. Among the adhesins, P
fimbriae show the strongest disease association in clinical stud-
ies. P fimbriae contribute to the establishment of bacteriuria by
binding to the -D-galactopyranosyl-(1-4)--D-galactopyrano-
side receptor epitope in the globoseries of glycolipids (29) and
activate innate immune responses in animal models and in the
human urinary tract (3, 37, 38, 54–56). Type 1 fimbriae also
enhance colonization and induce immune responses in the
mouse UTI model (8). Type 1 fimbriae confer binding to -D-
mannosylated proteins, such as uroplakins, which are abundant
in the bladder (53). Both P and type 1 fimbriae recognize their
receptor targets by virtue of organelle tip-located adhesins
(PapG and FimH, respectively) (27).
The phase-variable surface-located adhesin antigen 43
(Ag43) is also associated with urovirulence (1). Ag43 is a rep-
resentative member of the autotransporter (AT) family. AT
proteins are unique in that their primary sequence is sufficient
to direct their transport across the bacterial membrane system
and final routing of a variable passenger domain (alpha-do-
main) to the cell surface. AT proteins are generally very similar
with respect to the structure of the transporter module (beta-
domain) that assists the transport of the alpha-domain across
the outer membrane, whereas they differ substantially in the
alpha-domain, which determines the unique functional char-
acteristics of AT proteins (17, 18). Once at the bacterial sur-
face, the alpha-domain may be processed and released into the
extracellular surroundings (e.g., Pet and EspP), or it may be
cleaved but remain in contact with the cell surface via nonco-
valent interactions with the beta-domain (e.g., Ag43 and
AIDA) (18). Thus, AT proteins have diverse functions and
range from cell-associated adhesins to secreted toxins (17, 18).
Ag43 (encoded by the flu gene) is a self-recognizing AT
adhesin that confers characteristic surface properties on host
cells, such as autoaggregation and a frizzy colony morphology
(14, 15). Large amounts of this protein are expressed (approx-
imately 50,000 copies per cell), and the protein promotes bac-
terial biofilm formation (9, 24–26, 36, 42, 43, 44). The phase-
variable expression of Ag43 occurs at switching rates of 103
per cell per generation due to the concerted actions of Dam
methylase (positive regulation) and OxyR (negative regula-
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tion) (19, 43, 46, 52). Glycosylation of Ag43 occurs in some
wild-type UPEC strains, and Ag43 glycosylation in recombi-
nant E. coli enhances binding to HEp-2 cells (47).
A recent genome comparison analysis revealed that the se-
quenced genome of UPEC strain CFT073 encodes at least 10
putative AT proteins (35). CFT073 has two copies of the Ag43-
encoding flu gene, both of which are located on pathogenicity
islands. The two genes (fluA/upaF and fluB/upaD) are not
identical; they share 91% conservation at the nucleotide se-
quence level and 90% identity at the amino acid level. The
predicted alpha-domain of their protein products (Ag43a and
Ag43b) shares 81.7 and 78.4% amino acid identity, respec-
tively, with the K-12 Ag43 alpha-domain. The two predicted
proteins themselves share 85% amino acid identity in the en-
tire alpha-domain. Recently, the region of Ag43 responsible
for autoaggregation was localized to the first 160 amino acids
of the mature protein (26). The Ag43a and Ag43b proteins
share only 76% amino acid identity in this region.
While the function of Ag43 is well documented, its precise
role in UPEC disease pathogenesis remains to be elucidated.
Ag43 is expressed on the surface of UPEC cells located within
intracellular biofilm-like bacterial pods in the bladder epithe-
lium, indicating that it may contribute to survival and persis-
tence during prolonged infection (1). The in vivo expression of
Ag43 by UPEC has also been demonstrated via direct exami-
nation of infected human urine using immunofluorescence mi-
croscopy (34). The biological significance of multiple copies of
the flu gene is also unclear. Here, we characterized the func-
tion of both Ag43 variants of UPEC CFT073 and investigated
their role in virulence. The fluA and fluB genes were cloned,
their protein products were characterized, and their functions
were studied both in the heterologous E. coli K-12 host and in
UPEC CFT073. Deletion and expression-controlled mutants
were compared to wild-type CFT073 in a mouse UTI model,
and the results revealed an important contribution of Ag43a to
long-term persistence in the bladder. The findings indicate a
role for distinct Ag43 variants in UPEC disease pathogenesis
and identify Ag43 as another class of pathogenicity-adapted
cell surface proteins that possess amino acid alterations that
are associated with distinct virulence-related functions.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains and plasmids
used in this study are listed in Table 1. The uropathogenic and commensal E. coli
strains used to study the prevalence of the flu gene were obtained from the
Princess Alexandra Hospital (Brisbane, Australia) or were part of the ECOR
collection. Cells were routinely grown at 37°C on solid lysogeny broth (LB)
medium or in liquid (4) supplemented with the appropriate antibiotics, including
kanamycin (50 g/ml), chloramphenicol (25 g/ml), ampicillin (100 g/ml),
apramycin (30 g/ml), and zeocin (50 g/ml). For growth in defined conditions,
M9 and morpholinepropanesulfonic acid (MOPS) glucose media (41) were used
as indicated below. Plasmid pCO2 contains the flu gene from MG1655 and was
created by inserting a kanamycin resistance-encoding gene into the HindIII site
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Reference or source
E. coli K12 strains
MS427 MG1655 flu 36
OS56 MG1655 flu Gfp, Ampr 48
MS1199 pBAD/MycHisA in OS56 This study
MS1230 pCO2 in OS56, Ampr Kmr This study
MS1231 pCO3 in OS56, Ampr Kmr This study
MS1232 pCO4 in OS56, Ampr Kmr This study
E. coli CFT073
strains
CFT073 Wild-type UPEC isolate 31
CFTfluA CFT073 fluA::Apra, Aprar This study
CFTfluB CFT073 fluB::cat, Cmr This study
CFTfluA fluB CFT073 fluA::Apra fluB::cat, double mutant, Aprar Cmr This study
CFTfluB CFT073 ampPcLfluB, constitutively expressed Ag43b This study
CFTfluA fluB CFT073 fluA::Apra ampPcLfluB constitutively expressed Ag43b and Ag43a is absent, Aprar
Ampr
This study
CFTfluB CFT073 kmPcLfluA, constitutively expressed Ag43a This study
CFTfluA fluB CFT073 kmPcLfluA fluB::cat, constitutively expressed Ag43a and Ag43b is absent, Kmr Cmr This study
CFTfluA fluB CFT073 kmPcLfluA ampPcLfluB, constitutively expressed Ag43a and Ag43b, Kmr Ampr This study
CFToxyR CFT073 oxyR::Zeo, Zeor This study
CFToxyR fluA CFT073 oxyR::Zeo fluA::Apra, Zeor Aprar This study
CFToxyR fluB CFT073 oxyR::Zeo fluB::cat, Zeor Cmr This study
CFToxyR fluA fluB CFT073 oxyR::Zeo fluA::Apra fluB::cat, Zeor Aprar Cmr This study
Plasmids
pKKJ143 flu gene from MG1655 in pBADMycHisA, Ampr 23
pLH6 fluB gene (c1273) from CFT073 in pBADMycHisA, Ampr 26
pLH26 fluA gene (c3655) from CFT073 in pBADMycHisA, Ampr 26
pCO2 flu gene from MG1655 in pBADMycHisA-kan, Ampr Kmr This study
pCO3 fluB gene (c1273) from CFT073 in pBADMycHisA-kan, Ampr Kmr This study
pCO4 fluA gene (c3655) from CFT073 in pBADMycHisA-kan, Ampr Kmr This study
pHHA13 Type 1 fimbrial gene cluster from PC31 in pACYC184 H. Hasman
a Km, kanamycin; Cm, chloramphenicol; Amp, ampicillin; Apra, apramycin; Zeo, zeocin.
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of plasmid pKKJ143 (23). Plasmids pCO3 (with fluB from CFT073) and pCO4
(with fluA from CFT073) were constructed by insertion of a kanamycin resis-
tance-encoding gene into the HindIII sites of plasmids pLH6 and pLH26, re-
spectively (26). Resistance to kanamycin was required to facilitate transforma-
tion of these plasmids into the flu gfp K-12 strain OS56. In all constructs,
expression of each flu gene is under control of the arabinose-inducible araBAD
promoter (13). All plasmid constructs were verified by sequence analysis.
DNA manipulations and genetic techniques. DNA techniques were performed
as described by Sambrook et al. (41). Isolation of plasmid DNA was carried out
using a QIAprep Spin miniprep kit (QIAGEN). Restriction endonucleases were
used according to the manufacturer’s specifications (New England Biolabs).
Chromosomal DNA purification was performed using a GenomicPrep cell and
tissue DNA isolation kit (Amersham Pharmacia Biotech Inc.). Oligonucleotides
were purchased from Sigma, Australia or Sigma, France. All PCRs were per-
formed with the Expand High Fidelity polymerase system (Roche) used as
described by the manufacturer. Amplified products were sequenced to ensure
fidelity of the PCR. DNA sequencing was performed using an ABI Big Dye
ver3.1 kit (ABI) by the Australian Genome Research Facility, Brisbane. Primers
for flu gene prevalence studies were designed for conserved (5	-GGGTAAAG
CTGATAATGTCG and 5	-GTTGCTGACAGTGAGTGTGC) and variant (5	-
GCACTGGTTACCAGYAC and 5	-GGGACTTCWGCACGATAA) regions.
The following program was used: 25 cycles of 94°C for 15 s, 50°C for 15 s, and
72°C for 1 min.
Construction of deletion and expression mutants. In order to interrupt the fluA
and fluB genes in CFT073, as well as to place chromosomal target genes under
control of the PcL cassette (S. Da Re et al., submitted for publication), we used a
three-step PCR procedure described previously (6, 30) and at http://www.pasteur.fr
/recherche/unites/Ggb/matmet.html. The primers used to disrupt or insert the cas-
sette upstream of the genes used in this study are described in Table 2.
Reverse transcription (RT)-PCR. Cells were grown to the exponential phase in
LB and resuspended directly in an equal volume of ice-cold RNAlater (Ambion).
Total RNA was isolated and purified using an RNeasy mini kit (QIAGEN). After
purification, RNA was treated with RNase-free DNase I to remove contaminat-
ing DNA and repurified using QIAGEN RNeasy columns. RNA samples were
quantified spectrophotometrically at 260 nm and were additionally checked by
gel electrophoresis. Purified total RNA was precipitated with ethanol and stored
at 80°C until further use. RNA was converted to cDNA using SuperScript II as
described by the manufacturer (Invitrogen Life Technologies). cDNA was used
directly as a template for PCR using primers specific for fluA (primers 566 and
567) and fluB (primers 568 and 569). A negative control using the original RNA
was always run in parallel to confirm the absence of contaminating DNA.
Autoaggregation assay. In order to monitor the observed differences in auto-
aggregation, we devised an assay to monitor bacterial settling kinetics over time.
Overnight LB cultures supplemented with the appropriate antibiotics and in-
ducer were mixed well prior to the start of the assay. Four 50-l samples were
taken approximately 0.5 cm below the surface of the liquid cultures at 15-min
intervals and transferred to a round-bottom microtiter plate (TPP, Europe), and
the optical density at 600 nm (OD600) was determined with a microtiter plate
reader. The data are shown below as the mean absorbance value 
 standard
deviation, where the degree of autoaggregation is inversely proportional to the
turbidity.
Release of the alpha-domain of Ag43 and immunodetection. Cells from over-
night LB cultures were harvested by centrifugation, washed in 0.9% (wt/vol)
NaCl, and resuspended in 1 ml of 75 mM NaCl–0.5 mM Tris (pH 7.4) to an
OD600 of 15. The alpha-domain of Ag43 was released from the surface of the
cells by heating at 60°C for 3 min. The cells were immediately removed by
centrifugation, and the resultant protein in the supernatant was precipitated
overnight at 4°C with 10% (vol/vol) trichloroacetic acid (TCA). The pellet was
washed with 500 l of 80% acetone and dried. Samples were boiled for 3 min
prior to gel electrophoresis, and in each case an amount equivalent to 2.0 OD600
units was loaded onto the gel. Proteins were transferred to a polyvinylidene
difluoride membrane, and immunodetection was performed using a 1:10,000
dilution of polyclonal rabbit antiserum raised against the alpha-domain of Ag43
(a kind gift from P. Owen).
Biofilm assays. Biofilm formation on polystyrene surfaces was monitored by
using 96-well microtiter plates (IWAKI) essentially as previously described (45).
TABLE 2. Primers used in this study
Target gene Primer name Primer sequence
fluA c3655.500.5 CACGCACGGTTCTGCGTGCCGTC
c3655.500-3 GACTGAGCATATTTGAGTGCCC
c3655.cat.L-3 CTGCGAAGTGATCTTCCGTCACAGGGCTCTGCCCTCCGCCATCACGA
c3655.cat.L-5 GATGAGTGGCAGGGCGGGGCGTAACTGAATGTGACCTTCTGACAGAAC
c3655.ext-5 CAGCCTGCTGTTTAACAATAAC
c3655.ext-3 CGCATGTCAACAGGTTTAATTGC
c3655.xBAD-500.5 CACGCACGGTTCTGCGTGCCGTC
c365.xBAD-500-3 GCTCTGCCCTCCGCCATCACGA
c3655.xBAD.L-3 GAATCCCTGCTTCGTCCATTTGACAAGCTATTGCACGGACAAGAGAGACA
c3655.xBAD.L-5 GTTTCTCCATACCCGTTTTTTTGGTCCTGTTAGCAACGTGCGCAGATA
c3655.PcL.L-3 GTGAGAATTACTAACTTGAGCGAAAAGCTATTGCACGGACAAGAGAGACA
c3655.PcL.L-5 CGGTGATAATGGTTGCATGTATATCCTGTTAGCAACGTGCGCAGATA
c3655.xBAD.ext-5 CAGCCTGCTGTTTAACAATAAC
c3655.xBAD.ext-3 CCACTGCTCACCTCTGTTATCCAG
566 CAACCAGAAAGGAAAGCTGCAGGTG
567 TTCCCGGAAAGGGTAAGTATGGCGC
fluB c1273.500.5 TCCGTACGGCCCTGCGCGCTGTTC
c1273.500-3 TGATATCTTCAGGTGTGAGCCCG
c1273.apra.L-3 CACCCAGCCTGCGCGAGCAGGGGAGAAGCCTTCCCACGCAAATTCTG
c1273.apra.L-5 CGCCAGTCGATTGGCTGAGCTCATGAGAATGTGACCTTCTGATAATTCTG
c1273.ext-5 CGGTGGACTCCGGGTTATTC
c1273.ext-3 CAGCCAGCCAGTACAACAACCC
c1273.xBAD-500.5 CCGTACGGCCCTGCGCGCTGTTC
c1273.xBAD-500-3 GAAGCCTTCCCACGCAAATTCTG
c1273.xBAD.L-3 GAATCCCTGCTTCGTCCATTTGACTGATTGTTGCACGGACAAGAAAGGTG
c1273.xBAD.L-5 GTTTCTCCATACCCGTTTTTTTGGACCCGTTAGCAATGTATGCAGACA
c1273.PcL.L-3 GTGAGAATTACTAACTTGAGCGAATGATTGTTGCACGGACAAGAAAGGTG
c1273.PcL.L-5 CGGTGATAATGGTTGCATGTACTAACCCGTTAGCAATGTATGCAGACA
c1273.xBAD.ext-5 TCGGTGGACTCCGGGTTATTC
c1273.xBAD.ext-3 TTGATCACCGCCGTTAAGGACAG
568 CAGAACGGCGAGCTGAGGGTTC
569 CCGGCAAGGGTAAACGTGGCA
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Briefly, cells were grown for 24 h in LB (containing 0.2% arabinose for induction
of flu gene expression) at 37°C, washed to remove unbound cells, and stained
with crystal violet. Quantification of bound cells was performed by addition of
acetone-ethanol (20:80) and measurement of the dissolved crystal violet at
OD600. Flow chamber experiments were performed as previously described (25,
44). Briefly, biofilms were allowed to form on glass surfaces in a multichannel
flow system that permitted online monitoring of community structures. Flow cells
were inoculated with OD600-standardized cultures pregrown overnight in MOPS
medium containing chloramphenicol. Glucose was used as the sole carbon source
at a concentration of 0.002%. Biofilm development was monitored by confocal
scanning laser microscopy at 15 h after inoculation. Microfermentor experiments
were performed as previously described (12). Briefly, overnight cultures were
grown in LB and LB containing 0.2% arabinose at 37°C. Inoculation was per-
formed by dipping the microfermentor removable spatula in a culture containing
108 bacteria/ml for 2 min and subsequently reintroducing the spatula into the
microfermentor. The medium was pumped through the microfermentors at a
constant rate (0.75 ml/min). The OD570 of each resulting suspension was then
determined after 24 h. This optical density directly reflected the biomass on the
spatula. All experiments were performed in triplicate.
Microscopy and image analysis. All microscopic observation and image ac-
quisition were performed with a scanning confocal laser microscope (TCS4D;
Leica Lasertechnik, GmbH, Heidelberg, Germany) equipped with detectors and
filters for monitoring green fluorescent protein. The images below (see Fig. 3)
are representative of horizontal sections collected within each biofilm and ver-
tical sections representing the yz plane and the xz plane. Vertical cross sections
through the biofilms were generated by using the IMARIS software package
(Bitplane AG, Zu¨rich, Switzerland) running on a Silicon Graphics Indigo2 work-
station (Silicon Graphics, Mountain View, CA). Images were further processed
for display by using Photoshop software (Adobe, Mountain View, CA).
Mouse model of UTI. The mouse model of UTI described previously was used
for this study (39). Female C57BL/6 mice (8 to 10 weeks old) were purchased
from the Animal Resources Center, Western Australia, and were housed in
sterile cages with ad libitum access to sterile water. Urine was collected from
each mouse 24 h prior to challenge and examined microscopically with a hemo-
cytometer and by culture. Mice with a combination of 5  102 CFU of bacteria
per ml of urine and 2  105 white blood cells in urine were defined as having
a preexisting condition and were excluded from the study. Mice were anesthe-
tized by brief inhalation exposure to isoflurane, and the periurethral area was
sterilized by swabbing it with a 10% povidone–iodine solution, which was re-
moved with sterile phosphate-buffered saline (PBS). Mice were catheterized
using a sterile Teflon catheter (inside diameter, 0.28 mm; outside diameter; 0.61
mm; length, 25 mm; Terumo) by inserting the device directly into the bladder
through the urethra. A 25-l inoculum containing 5  108 CFU of bacteria in
PBS containing 0.1% India ink was instilled directly into the bladder using a 1-ml
tuberculin syringe attached to the catheter. The catheter was removed immedi-
ately after the challenge, and mice were returned to their cages. Urine was
collected from each mouse at 18 h after inoculation for quantitative colony
counting. Groups of mice were euthanized at 18 h and 5 days after challenge by
cervical dislocation; bladders were then excised aseptically, weighed, and homog-
enized in PBS. Bladder homogenates were serially diluted in PBS and plated
onto LB agar for colony counting. Data are expressed below as the mean total
number of CFU per 0.1 g of bladder tissue 
 standard error of the mean. All
animal experiments were repeated at least twice with a minimum group size of
eight, and the data shown below are composites from all independent experi-
ments.
Statistics. Differences in aggregation and biofilm phenotypes (mean optical
density values) between Ag43-expressing E. coli strains and mutants were com-
pared using an independent sample t test in the SPSS v9.0.2 software package.
Mean bacterial titers of UPEC strains and mutants recovered from bladders
were compared using an independent sample t test with log-transformed data.
Normal distribution parameters for the different data sets were estimated using
P-P plots and histogram analysis. P values of 0.05 were considered significant.
RESULTS
Multiple copies of the flu gene are common in both uro-
pathogenic and commensal E. coli. CFT073 contains two cop-
ies of the flu gene (26). A comparison of the amino acid
sequence encoded by these two genes with the K-12 Ag43
amino acid sequence is shown in Table 3. In order to remain
consistent with our previous description of the two flu genes
from CFT073 (26), we used the following terminology: fluA
encoding Ag43a (also described as upaF encoding c3655) and
fluB encoding Ag43b (also described as upaD encoding c1273).
To assess the prevalence of the flu gene in UPEC and to
compare UPEC to commensal E. coli, we devised a PCR using
a single set of highly conserved primers designed from a mul-
tiple-sequence alignment of the flu genes available in the NCBI
database. The primers were designed such that they could
identify the flu gene irrespective of known nucleotide sequence
variations in the region encoding the alpha-domain. PCR
screening of the ECOR collection and our laboratory collec-
tion revealed that the flu gene was present in 83% (30/36) of
UPEC strains, compared to 56% (35/62) of nonpathogenic E.
coli strains. Next, we devised a second PCR that enabled rapid
identification of one common class of flu gene variants, specif-
ically those that contain a 216-bp deletion within the alpha-
encoding domain (26). Using primers that flank this region, we
screened our collections for the deletion and observed that
22% (8/36) of the uropathogenic and 18% (11/62) of the com-
mensal E. coli strains tested contained two amplification prod-
ucts that were different sizes. Thus, multiple copies of the flu
gene are common in both uropathogenic and commensal E.
coli strains.
Cloning and expression of the flu genes from UPEC
CFT073. The fluA and fluB genes were amplified by PCR from
UPEC CFT073 and cloned as transcriptional fusions behind
the tightly regulated araBAD promoter in the pBAD/Myc-
HisA expression vector (26). To characterize each of the en-
coded Ag43 proteins, the resultant plasmids (pCO3 [fluB] and
pCO4 [fluA]), as well as pCO2 bearing the K-12 strain MG1655
flu gene, were all transformed into the previously described E.
coli flu mutant strain OS56 (25). This strain is unable to
mediate the classical cell aggregation and biofilm phenotypes
associated with Ag43 expression (36). In the case of the E. coli
K-12 Ag43 protein and other AT proteins associated with
diarrheagenic E. coli (AIDA-I and TibA), the -domain re-
mains attached to the -domain via noncovalent interactions.
This results in a unique property in that the protein can be
released and partially purified by brief heat treatment. E. coli
K-12 OS56 cells transformed with either pCO4 (Ag43a; strain
MS1232), pCO3 (Ag43b; strain MS1231), or pCO2 (K-12
Ag43; strain MS1230) were grown in LB in the presence of
0.2% arabinose, subjected to heat treatment, and purified by
TCA precipitation. Sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis (PAGE) analysis revealed that the
Ag43 proteins could be expressed at equivalent levels after
induction from each plasmid construct and released from the
cell surface following a brief heat treatment (Fig. 1A). The
identities of the Ag43 alpha-domain fragments were confirmed
by immunodetection using a serum raised against the alpha-
TABLE 3. Properties of UPEC CFT073 Ag43 adhesins
Gene c No.
% Amino acid
identity to
K-12 Ag43
-domain
% Amino acid
identity to
K-12 Ag43
-domain
Overall % amino
acid identity to
K-12 Ag43
fluA (upaF) c3655 81.7 97.1 88.9
fluB (upaD) c1273 78.4 95.1 86.2
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domain of Ag43 from E. coli K-12 (Fig. 1B). We noted that the
antiserum reacted more strongly with the K-12 Ag43 alpha-
domain subunit than with the CFT073 Ag43a and Ag43b al-
pha-domain subunits, which reacted similarly.
Ag43a and Ag43b from CFT073 mediate different levels of
bacterial aggregation. Cell-cell aggregation is a phenotype
classically associated with Ag43 expression (16). To test the
ability of the CFT073 Ag43a and Ag43b proteins to mediate
this phenotype, E. coli K-12 OS56 cells containing pCO4
(Ag43a), pCO3 (Ag43b), or pCO2 (K-12 Ag43) were grown in
LB with 0.2% arabinose and tested to determine their aggre-
gation properties. Although produced in similar quantities, the
Ag43a and Ag43b proteins promoted different degrees of cell
aggregation. Aggregation mediated by Ag43a was the strongest
and, analogous to the aggregation mediated by K-12 Ag43,
resulted in rapid flocculation and settling of cells from standing
overnight cultures (Fig. 2A). In contrast, aggregation mediated
by Ag43b was less pronounced. In line with previous observa-
tions with other AT proteins that mediate cell aggregation, this
property could be blocked by the introduction of a plasmid
(pHHA13) conferring constitutive expression of type 1 fim-
briae (Fig. 2B). Similar levels of the alpha-domain subunit
were detected in the presence and in the absence of plasmid
pHHA13, indicating that type 1 fimbria expression did not
affect the surface presentation of Ag43a or Ag43b (Fig. 2C).
Thus, Ag43a and Ag43b mediate phenotypes associated with
different degrees of cell aggregation. Furthermore, aggregation
can be physically blocked by fimbria expression, a property that
may have in vivo consequences and affect CFT073 Ag43-me-
diated phenotypes during in vitro growth (see below).
Biofilm formation properties of the Ag43a and Ag43b ad-
hesins. To determine whether the CFT073 Ag43a and Ag43b
proteins promote biofilm formation, gfp-tagged cells harboring
each of the corresponding plasmids were tested to determine
their abilities to form biofilms in static and dynamic biofilm
assays. First, we employed a static nontreated polystyrene mi-
crotiter plate model and showed that both Ag43 variants pro-
mote biofilm formation after growth in LB (Fig. 3A). Next, we
tested the abilities of the Ag43 proteins to promote biofilm
formation in dynamic conditions using microfermentor and
continuous-flow chamber models; the latter model allowed us
to monitor bacterial distribution within an evolving biofilm at
the single-cell level due to the combination of gfp-tagged cells
and scanning confocal laser microscopy. Ag43a promoted the
strongest biofilm growth under both experimental scenarios
and in the flow chamber produced a structure with a depth of
approximately 10 m (Fig. 3B and C). Taken together, the
data suggest that strong Ag43a-mediated aggregation en-
hances biofilm formation by E. coli K-12.
Both fluA and fluB are expressed in CFT073. Our analysis of
the function of the Ag43a and Ag43b proteins from CFT073
involved cloning of the genes and expression from an inducible
promoter. To determine whether the fluA and fluB genes are
expressed by wild-type strain CFT073, transcription of each
gene was analyzed by RT-PCR. RNA was extracted from
CFT073 cells grown in LB and converted to cDNA, and a
specific PCR was performed for each of the genes (Fig. 4). In
both cases, an amplification product was obtained and DNA
sequencing confirmed the specificity of the reaction. No PCR
products were obtained from the RNA sample prior to cDNA
synthesis. These results demonstrate that the fluA and fluB
genes located on the CFT073 chromosome are transcribed
during growth in LB. However, the fluB gene appeared to be
expressed at lower levels than the fluA gene.
Deletion of the flu genes in CFT073 and repression of flu
expression by OxyR. To further examine the role of Ag43a and
Ag43b in UPEC virulence, specific deletion mutants were con-
structed in CFT073. Chromosomal construction was per-
formed by -red recombination of linear DNA (6, 30). Mutants
containing individual fluA and fluB deletions, as well as a fluA
fluB double deletion, were created. These mutants did not
display any differences in the ability to form a biofilm in the
microtiter plate assay (Fig. 5). Western blot analysis using
Ag43-specific antiserum failed to detect expression of Ag43a
or Ag43b in CFT073 (Fig. 5). However, after prolonged expo-
sure a faint band was observed in CFT073 that was absent in
FIG. 1. (A) Coomassie brilliant blue-stained SDS-PAGE gel demonstrating Ag43 expression in E. coli MG1655 flu strains, including MS1231
(pCO3, Ag43b), MS1232 (pCO4, Ag43a), and MS1230 (pCO2, Ag43 K-12). Production of each Ag43 variant was induced by 0.2% arabinose.
Protein preparations were obtained by subjecting cells to a brief heat treatment, centrifugation, and purification of heat-released proteins by TCA
precipitation. Lane M contained markers. (B) Western blot analysis using a serum directed against the alpha-domain of Ag43 from E. coli K-12.
Expression of Ag43b (MS1231), Ag43a (MS1232), and Ag43 from K-12 (MS1230) was detected only following induction with 0.2% arabinose. The
serum reacted most strongly against the K-12 Ag43 alpha-domain subunit; the Ag43a and Ag43b variants reacted more weakly, but the levels for
these variants were comparable. The asterisk indicates specific degradation products of the different Ag43 variants.
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the fluA mutant, demonstrating that there was very low expres-
sion of Ag43a in CFT073 (data not shown). On the other hand,
the same prolonged exposure did not result in detection of
Ag43b.
In E. coli K-12, the expression of Ag43 is phase variable due
to the concerted action of the Dam methyltransferase (positive
regulation) and OxyR (negative regulation) (28). The CFT073
fluA and fluB promoter regions both contain three GATC sites
which overlap a putative recognition sequence for OxyR. How-
ever, the putative OxyR binding sites are not the same as the
site found in E. coli K-12 and contain 31/37 identical nucleo-
tides (Fig. 5). In E. coli K-12, when the GATC sites are meth-
ylated, OxyR cannot bind; conversely, bound OxyR prevents
methylation (29). The oxyR gene was deleted in wild-type
strain CFT073, CFT073fluA, CFT073fluB, and CFT073fluA
fluB by -red recombination of linear DNA. Each of these
strains was then probed for Ag43 expression by immunodetec-
tion analysis using Ag43-specific antiserum. Ag43 expression
was observed in all oxyR mutants except CFT073fluA fluB (Fig.
5), indicating that the expression of both Ag43a and Ag43b is
repressed by OxyR. None of these strains displayed a positive
aggregation or biofilm formation phenotype (Fig. 5C and D),
further supporting the notion that the Ag43 function in CFT073
is masked by larger cell surface structures.
CFT073 fluAmutant displays reduced long-term persistence
in the mouse bladder. The CFT073 fluA and fluB mutants were
tested to determine their abilities to survive in the mouse
urinary tract. At day 1 following infection, we did not observe
any significant difference in the abilities of the wild-type and
mutant strains to colonize the mouse bladder. However, at day
5 following infection, we observed a significant reduction (P 
0.01) in the ability of the CFT073 fluA mutant to colonize the
bladder (Fig. 6). No significant difference was observed when
the fluB mutant was compared with the wild-type CFT073
strain. No colonization of the kidney was observed for any of
the strains tested. Taken together, these data demonstrate that
fluA (encoding Ag43a) is required for long-term colonization
of the mouse bladder.
Construction and analysis of CFT073 strains constitutively
expressing Ag43a and Ag43b. The phase-variable expression of
Ag43 in E. coli K-12 prompted us to use a second approach to
study the effect of Ag43a and Ag43b in CFT073. To this end,
we constructed a unique set of Ag43 overexpression strains by
inserting a chromosomally located constitutive promoter up-
stream of fluA or fluB. The strains constitutively expressing
Ag43 were constructed using a modification of the RExBAD
expression cassette system (40; S. Da Re et al., submitted for
publication). This resulted in insertion of the PR constitutive
promoter in front of the fluA or fluB gene. We constructed the
following Ag43a- and Ag43b-expressing strains: CFTfluA
fluB (expressing only fluA), CFTfluA fluB (expressing only
fluB), and CFTfluA fluB (expressing both fluA and fluB).
Each strain produced the appropriate Ag43 variant(s), as
shown by Western blot analysis (Fig. 7A). However, neither of
the Ag43 proteins promoted aggregation or biofilm formation
in this background (Fig. 7B; data not shown). Ag43 belongs to
a class of short non-organelle-type adhesins that are predicted
to protrude about 10 nm from the bacterial surface (22). Thus,
Ag43-mediated cell aggregation requires close cell-cell con-
tact. The inability of Ag43a and Ag43b to mediate aggregation
and biofilm formation in CFT073 is probably due to the ex-
pression of other large cell surface structures, such as fimbriae,
flagella, lipopolysaccharide, and the capsule, which have pre-
viously been shown to physically shield and block the close
cell-cell contact required for Ag43-mediated cell aggregation
(2, 14, 42, 48, 49, 51). We attempted to address this possibility
by deletion of either the type 1 fimbria- or capsule-encoding
genes in CFT073 strains expressing either fluA or fluB or both
fluA or fluB; however, this did not increase the biofilm forma-
tion properties (Fig. 7B). It is therefore likely that several
differentially expressed surface factors affect this phenotype.
FIG. 2. (A) Autoaggregation assay demonstrating the settling profiles
for liquid suspensions of E. coli OS56 (MG1655flu, Gfp) containing the
following plasmids: (i) pBADMycHisA (MS1199), (ii) pCO2 (K-12 Ag43,
MS1230), (iii) pCO3 (Ag43b, MS1231), and (iv) pCO4 (Ag43a, MS1232).
All strains were grown in the presence of 0.2% arabinose to induce Ag43
expression. Expression of Ag43 led to significant autoaggregation of
MS1230, MS1231, and MS1232 compared to the autoaggregation of con-
trol strain MS1199 (at 60 to 120 min, P  0.05 for each strain, as deter-
mined by the independent sample t test). Furthermore, MS1232 cells
expressing Ag43a exhibited significantly stronger autoaggregation than
their MS1231 Ag43b-expressing counterparts (at 60 to 120 min, P 0.002,
as determined by the independent sample t test). (B) Same assay in the
presence of type 1 fimbria expression. MS1199, MS1230, MS1231, and
MS1232 were transformed with pHHA13 (which encodes the ability to
express type 1 fimbriae) and grown in the presence of 0.2% arabinose as
described above to induce Ag43 expression. The presence of type 1 fim-
briae on the cell surface resulted in prevention of Ag43-mediated aggre-
gation. (C) Western blot of Ag43 alpha-domain subunit proteins liberated
from E. coli MS1231 (Ag43b), MS1232 (Ag43a), MS1231(pHHA13)
(Ag43b Fim), and MS1232(pHHA13) (Ag43a Fim). Overexpres-
sion of type 1 fimbriae did not affect the amount of Ag43 present at the
cell surface of each strain.
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Constitutive expression of Ag43a promotes long-term per-
sistence in the mouse bladder. Despite the in vitro phenotype
of our CFT073 Ag43-expressing strains, the decreased bladder
colonization observed with the CFT073 fluA mutant suggested
that random in vivo phase variation of multiple cell surface
structures may contribute to Ag43 function during disease. To
assess the impact of the Ag43a and Ag43b proteins on the
ability of CFT073 to survive in the mouse urinary tract, we
tested the strains expressing either fluA or fluB or both fluA
and fluB during early and long-term colonization of the mouse
urinary tract (Fig. 6). At day 1 following infection, we observed
significantly reduced colonization of the bladder by CFT073
strains expressing Ag43b. This effect occurred independent of
Ag43a expression (compare the results for CFTfluA fluB and
CFTfluA fluB to those for CFT073, CFTfluA fluB, or CFT-
fluA fluB). Thus, Ag43b overexpression appears to impair
colonization of the bladder epithelium during the initial phase
of infection. At day 5 following infection, however, we ob-
served a distinct change in the survival pattern of the individual
strains. The numbers of both CFT073 strains not expressing
Ag43a recovered in the bladder were significantly lower than
the numbers of CFT073 and the two Ag43a-expressing strains.
This effect was observed independent of Ag43b expression
(compare the results for CFTfluA fluB and CFTfluA fluB to
those for CFT073, CFTfluA fluB, or CFTfluA fluB). Taken
together, these data demonstrate that while constitutive ex-
pression of Ag43b impairs the initial colonization, the presence
of Ag43a is necessary for longer-term persistence in the mouse
bladder. Moreover, at day 5, expression of Ag43a appears to
FIG. 3. Biofilm formation by E. coli MG1655flu cells harboring plasmids expressing Ag43a and Ag43b. The effect of each Ag43 variant on
biofilm formation was assessed in E. coli OS56 (MG1655flu, Gfp) cells containing the following plasmids: (i) pBADMycHisA (MS1199), (ii)
pCO3 (Ag43b, MS1231), and (iii) pCO4 (Ag43a, MS1232). All strains were grown in the presence of 0.2% arabinose to induce Ag43 expression.
Three different assays were employed. (A) Static biofilm formation in polystyrene microtiter plates. Expression of Ag43 led to significant biofilm
formation by MS1231 and MS1232 compared to the biofilm formation by control strain MS1199 (P  0.05 for each strain, as determined by the
independent sample t test). (B) Dynamic biofilm formation in a microfermentor system. Expression of Ag43a led to significant biofilm formation
by MS1232 compared to the biofilm formation by control strain MS1199 (P  0.05, as determined by the independent sample t test). MS1231 cells
expressing Ag43b exhibited a small increase in biofilm formation compared to the biofilm formation by control strain MS1199, although the
difference was not statistically significant. (C) Dynamic biofilm formation using a flow chamber model. Biofilm development was monitored by
confocal scanning laser microscopy. The images are representative horizontal sections collected for each biofilm and vertical sections (to the right
of and below each larger panel, representing the yz plane and the xz plane, respectively) at the positions indicated by the white lines.
FIG. 4. RT-PCR analysis of fluA and fluB expression by CFT073.
Total RNA was extracted from CFT073 during exponential growth in
LB. Lane 1, fluA-specific PCR product (523 bp) obtained using cDNA
as the template; lane 2, negative control using RNA prior to cDNA
synthesis; lane 3, fluB-specific PCR product (518 bp) obtained using
cDNA as the template; lane 4, negative control using RNA prior to
cDNA synthesis; lane M, 1-kb Plus DNA ladder (Invitrogen).
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compensate for the inhibitory effect of Ag43b expression ob-
served at day 1. These findings are consistent with the reduced
persistence of the CFT073 fluA mutant in the bladder.
DISCUSSION
Attachment to host tissues is the first critical step in coloni-
zation and is mediated by bacterial adhesins. UPEC produces
a range of fimbrial and nonfimbrial adhesins that play a role in
virulence and contribute to persistent infection of the urinary
tract. Some UPEC fimbrial adhesins, including type 1 and P
fimbriae, have been well characterized with respect to their
expression, regulation, receptor-binding target, and role in vir-
ulence. Of the nonfimbrial adhesins, the AT family of proteins
represent a novel group of virulence factors because of their
role in adhesion, invasion, and biofilm formation in other or-
ganisms. Although UPEC possesses multiple AT-encoding
genes, very little is known about their function and role in
virulence. Here, we characterize two AT adhesins of UPEC
CFT073 (Ag43a and Ag43b) and demonstrate that the Ag43a
variant is able to promote biofilm formation and contributes to
long-term persistence in the urinary bladder.
Our approach to studying the function of the UPEC CFT073
Ag43a and Ag43b proteins involved the use of two host strains,
K-12 MG1655flu and CFT073. The K-12 MG1655flu strain
is well characterized and has been shown to be an ideal back-
ground strain to assess the function of AT adhesins (24, 25).
The Ag43a and Ag43b proteins had marked differences in the
ability to mediate aggregation, and Ag43a-mediated aggrega-
tion was stronger. These different biological properties were
not due to variations in the levels of Ag43a and Ag43b protein
expression, as determined by SDS-PAGE analysis and Western
blotting. The Ag43a- and Ag43b-mediated aggregation pheno-
type could be blocked by the concomitant expression of type 1
fimbriae, a finding that is consistent with other studies which
demonstrated that the intimate cell-cell contact required for
AT adhesin interaction can be physically blocked by the ex-
pression of larger surface structures, such as fimbriae, flagella,
lipopolysaccharide, and the capsule (2, 14, 42, 48, 51). We also
observed that Ag43-mediated aggregation was not manifested
in CFT073 when the proteins were constitutively expressed or
following deletion of the oxyR repressor. We attempted to
address this issue by constructing a deletion in the type 1
fimbrial genes and the capsule-encoding kpsD gene; however,
this did not have any effect on cell aggregation or biofilm
formation, suggesting that additional factors may also mask the
Ag43 function in CFT073.
One of the mechanisms by which UPEC promotes the for-
mation of biofilms is via the expression of proteins that medi-
ate cell-cell aggregation. Our previous work demonstrated that
FIG. 5. (A) Schematic representation of the OxyR binding sites
and adjacent nucleotide sequences of the flu gene from E. coli K-12
and the fluA and fluB genes from CFT073. The putative OxyR binding
sites are underlined, the GATC methylation sites are indicated by bold
type, and the nucleotide sequence differences are indicated by shading.
(B) Ag43 expression in CFT073 flu and oxyR mutants. Protein prepa-
rations were obtained by subjecting cells to a brief heat treatment,
centrifugation, and subsequent SDS-PAGE and immunodetection
analysis using a serum directed against the -domain of Ag43 from E.
coli K-12. Whereas no Ag43 variants could be detected in wild-type
CFT073 in this image, longer exposure of the same membrane re-
vealed the presence of Ag43a but not Ag43b in CFT073 (data not
shown). Deletion of oxyR resulted in significant expression of both
Ag43a and Ag43b, demonstrating that OxyR represses both the fluA
and fluB genes in wild-type strain CFT073. (C) Autoaggregation assay
demonstrating the settling profiles for liquid suspensions of CFT073,
CFT073fluA, CFT073fluB, CFTfluA fluB, CFT073oxyR, CFT073oxyR
fluB, CFT073oxyR fluA, and CFT073oxyR fluA fluB. Deletion of oxyR
did not produce an aggregation phenotype. (D) Biofilm formation by
CFT073, CFT073fluA, CFT073fluB, CFTfluA fluB, CFT073oxyR,
CFT073oxyR fluB, CFT073oxyR fluA, and CFT073oxyR fluA fluB. De-
letion of oxyR gave rise to a biofilm phenotype similar to that of the
CFT073fluA, CFT073fluB, and CFT073fluA fluB strains.
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Ag43 (from E. coli K-12) is associated with the early stages of
biofilm development (44). However, Ag43 has also been shown
to be dispensable for biofilm formation as it can be replaced by
alternative factors, such as conjugative pili (12, 36). Here we
demonstrated that in a K-12 background only Ag43a is able to
promote strong biofilm formation using dynamic flow model
systems. The biofilm produced by the strain expressing Ag43a
is similar to the biofilm reported for the K-12 Ag43 in terms of
thickness and structure (25).
In UTI caused by UPEC, biofilm formation occurs within
superficial umbrella cells of the bladders of mice after infection
(1). The biofilms are pod-like structures that contain polysac-
charide-encased cell clusters expressing Ag43, and their for-
mation is postulated to be associated with long-term persis-
tence in the urinary bladder (10). The strain used in these
studies, UTI89, was recently sequenced and contains only one
copy of the flu gene (c1139) (7). The corresponding gene
product shares only 67% amino acid identity with the Ag43a
and Ag43b adhesins of CFT073, and the vast majority of the
differences occur in the passenger (exposed) domain of the
protein. Therefore, it is not possible to associate the biofilm
phenotype of UTI89 with that observed for Ag43a from
CFT073. It is likely that sequence divergence within the pas-
senger domain of Ag43 has resulted in the evolution of many
different pathogenicity-adapted variants that possess enhanced
biofilm formation properties. This may also be associated with
the glycosylation of some Ag43 variants, as has been observed
in UPEC strain 536 (47). Interestingly, UPEC CFT073 was a
poor biofilm former in all of our assays. Although we were able
to detect expression of the fluA and fluB genes by RT-PCR, we
detected only a low level of Ag43a by immunodetection anal-
ysis using heat-extracted protein samples prepared from wild-
type cultures. This type of differential expression of Ag43 vari-
ants has also been reported for UPEC strain 536, in which one
FIG. 6. (A) Persistence of wild-type strain CFT073 and CFT073 fluA- and fluB-deficient mutants in the bladders of C57BL/6 mice following
intraurethral challenge. At day 1 following infection, equivalent numbers of both flu deletion mutants and wild-type strain CFT073 were recovered.
At day 5 following infection, significantly lower numbers of the fluA deletion mutant than of wild-type strain CFT073 were recovered (P  0.01).
The data are the mean total numbers of CFU per 0.1 g of bladder tissue 
 standard errors of the means for 10 mice. (B) Persistence of E. coli
CFT073 and CFTfluA fluB, CFTfluA fluB, CFTfluA fluB, and CFTfluA fluB mutants in the bladders of C57BL/6 mice following intraurethral
challenge. At day 1 following infection wild-type strain CFT073 and the CFTfluA fluB and CFTfluA fluB strains colonized the bladder epithelium
significantly better than strains expressing Ag43b (P  0.028 for comparisons of all three of the strains with CFTfluA fluB and CFTfluA fluB).
At day 5 following infection constitutive expression of Ag43a in E. coli CFT073 promoted longer-term colonization in the bladder irrespective of
the presence of Ag43b (P 0.044 for comparisons of CFTfluA fluB and CFTfluA fluB with CFT073, CFTfluA fluB, or CFTfluA fluB). The data
are the mean total numbers of CFU per 0.1 g of bladder tissue 
 standard errors of the means for at least two independent experiments. The
following numbers of mice were used: on day 1, 29 mice for CFT073, 15 mice for CFTfluA fluB, 14 mice for CFTfluA fluB, 15 mice for CFTfluA
fluB, and 15 mice for CFTfluA fluB; on day 5, 18 mice for CFT073, 15 mice for CFTfluA fluB, 14 mice for CFTfluA fluB, 16 mice for CFTfluA
fluB, and 15 mice for CFTfluA fluB. An asterisk indicates that mean bacterial titers were compared using the independent sample t test after
log transformation of data to achieve normal distributions according to P-P plots and histogram analysis (SPSS v9.0.2; SPSS, Chicago, IL).
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of the two Ag43 variants, ORF52III, is expressed at higher
levels than the other, ORF47V (2).
Two strategies were employed to determine the role of
Ag43a and Ag43b in virulence in the mouse urinary tract. First,
deletion mutants were constructed and revealed a novel role
for Ag43a in long-term persistence in the bladder. The second
strategy employed an approach analogous to the previously
described RExBAD system (40), with the exception that we
inserted a constitutive promoter (PcL) upstream of each target
gene (S. Da Re et al., submitted). Since the two Ag43 proteins
are phase variable, this avoids reliance on the natural promoter
for flu expression and circumvents any pleiotropic effects that
would have resulted from the use of our oxyR mutants. Fur-
thermore, since the physiological conditions required for ex-
pression of Ag43a and Ag43b are not known, this enabled us to
compare the survival of CFT073 mutants containing deletions
in each gene. Expression of Ag43a in CFT073 was required for
optimum colonization of the mouse bladder when it was as-
sessed at 5 days as a prolonged infection model. This require-
ment for Ag43a for colonization was observed irrespective of
Ag43b expression, although Ag43b appeared to have a detri-
mental effect on bacterial colonization after 1 day of infection.
It is possible that Ag43b impedes the ability of CFT073 to
establish early colonization in the bladder by virtue of its
weaker aggregation- and biofilm-related properties. The dif-
ferential roles of these two homologous proteins in survival in
the urinary tract raise the possibility that they have evolved to
possess different functional properties. Indeed, our in vitro
aggregation and biofilm studies with these two proteins alluded
to such differences. The sequence of the promoter region of
the CFT073 fluA and fluB genes is not identical to the se-
quence of the corresponding promoter region of the K-12 flu
gene. In the 300-bp region upstream of the protein-encoding
sequence, fluA shares 89% (266/300) nucleotide sequence
identity with the same region in K-12, while fluB shares 81%
(243/300) nucleotide sequence identity. Despite these differ-
ences, derepression of both Ag43a expression and Ag43b ex-
pression was observed in a CFT073 oxyR background, demon-
strating that OxyR represses the expression of both fluA and
fluB in CFT073. The fact that the three GATC sites found in
the K-12 flu promoter region are also conserved upstream of
fluA and fluB in CFT073 suggests that Ag43a and Ag43b are
FIG. 7. (A) Immunodetection analysis of Ag43a and Ag43b proteins produced in CFT073 as a result of constitutive expression from PcL
promoter insertions. Protein preparations were obtained by subjecting cells to a brief heat treatment, centrifugation, and subsequent SDS-PAGE
and immunodetection analysis using a serum directed against the -domain of Ag43 from E. coli K-12. Each strain produced the appropriate Ag43
variant(s), as demonstrated by the different sizes of the alpha-domain and the degradation products (indicated by an asterisk). (B) Biofilm
formation in microtiter plates by CFT073 expressing Ag43 variants and capsule and type 1 fimbria mutant derivatives. WT, wild type.
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both phase variable and that the mechanism by which this
occurs is analogous to the mechanism for Ag43 in K-12 and is
coordinated by the combined action of Dam and OxyR. The
introduction of a constitutive promoter to control expression
of each gene, therefore, provided the added advantage of al-
lowing us to study the function of these adhesins in the context
of a defined wild-type UPEC strain and bypassing of the phase
variation mechanism for these two proteins. Our results sug-
gest that the phase variation of Ag43a and Ag43b in the mouse
urinary tract may be coordinated together with as-yet-unde-
fined environmental or other factors that favor Ag43a expres-
sion and therefore persistence in the bladder. The ability of
Ag43a to promote longer-term colonization in the bladder may
be due to its capacity to enhance biofilm formation, which
plays a role in resistance to host defenses and therefore the
establishment of longer-term infection. Alternatively, Ag43
may exert its effect by influencing the susceptibility of UPEC to
stress, a process that could be coordinately regulated via OxyR.
In line with this, Ag43-mediated aggregation has been shown
to enhance tolerance to bactericidal agents such as H2O2 (43).
Ag43a contributes to long-term persistence after establish-
ment of an initial infection, suggesting that its function comes
into play after fimbria-mediated specific adhesion. We de-
tected a low level of fluA and fluB gene expression by RT-PCR,
and Ag43a expression was observed by Western blot analysis.
The failure to detect Ag43b may have been due to a combina-
tion of lower expression and weak cross-reactivity with our
Ag43 antiserum. Although we did not observe a direct in vitro
phenotype for CFT073 strains constitutively expressing Ag43a
or Ag43b, our in vivo findings imply that phase variation of
fimbriae may be an important aspect of long-term survival and
adaptation in the mouse bladder. While cells expressing fim-
briae would not be able to aggregate, cells devoid of fimbriae
would be able to adapt to niche environments that favor ag-
gregation and biofilm development. In our forced Ag43 expres-
sion strains this effect would be enhanced even further as a
result of constitutive gene expression (i.e., the genes are al-
ready “on”). In support of this model others have demon-
strated the existence of an inverse relationship between type 1
fimbrial gene expression and P fimbrial gene expression (20,
50, 57). It has been proposed that during the course of an
infection type 1 fimbriae are important in the early stages;
however, as the infection progresses, increased expression of
motility and P fimbrial genes occurs at the expense of type 1
fimbrial expression (5). Such a model is also consistent with a
previous report of fimbria-mediated coordination of Ag43 ex-
pression (46). The long-term survival of UPEC in the urinary
tract has been linked to the formation of biofilm-like intracel-
lular bacterial communities and the formation of quiescent
intracellular reservoirs within the urinary bladder epithelium
(21, 32). It would be now be interesting to determine the role
of Ag43 in these survival mechanisms and to differentiate be-
tween the contributions of Ag43a and Ag43b to persistence in
the bladder.
E. coli is a highly diverse species, and over 250 serotypes
have been identified based on O, H, and K antigens. There is
extensive variation in the DNA content in different strain
types. The differences account for the versatility of E. coli with
respect to disease since different strains have acquired different
sets of virulence genes, which are typically located on patho-
genicity islands or on plasmids. A PCR screen using primers
designed for predicted conserved regions of the flu gene re-
vealed a difference in the prevalence of this gene between
uropathogenic and commensal E. coli strains. Three UPEC
strains have now been entirely sequenced, and a different pic-
ture has emerged in each case with respect to the location and
sequence of the flu gene. It therefore seems reasonable to
conclude that the pathogenicity island localization of the flu
gene contributes to its multiplicity in different E. coli strains.
The variable sequence of the alpha-encoding domain of Ag43
is consistent with data for other AT adhesins and suggests that
characterization of additional variants from other clinical iso-
lates may reveal novel phenotypic properties of this versatile
adhesin.
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